BD SWITZERLAND SARL has recalled approximately 3,884,670 BD PhaSeal drug transfer devices because they were shipped to the U.S. market without a U.S. version of the instructions for use. These devices, which include various injectors, protectors, connectors, and adapters, are closed systems used by healthcare professionals to safely handle and transfer hazardous drugs. While no incidents or injuries have been reported to date, the lack of proper instructions could lead to errors in how the devices are used, potentially exposing medical staff or patients to hazardous substances. Affected products were distributed nationwide across at least 38 states and the District of Columbia.
If healthcare professionals do not have access to the correct U.S. instructions, the device may be assembled or operated incorrectly. This poses a risk of exposure to hazardous drugs for the staff and potential treatment errors for patients.
No lot numbers specified in recall data.
No lot numbers specified in recall data.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.